rAAV-PAH (Pfizer)

N/A

Report date: 2025/01/26 16:24:12

Base Information

Drug NamerAAV-PAH (Pfizer)
Drug Alias NamePAH gene therapy (Pfizer)
ClassificationOther
Mechanisms of ActionPhenylalanine hydroxylase stimulants
TargetsPhenylalanine hydroxylase
Therapy Area/IndicationsPhenylketonurias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer Inc
Inactive CompaniesN/A
Active IndicationsPhenylketonurias
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A